INTRODUCTION {#sec1-1}
============

*Candida* species are currently the fourth-leading cause of hospital- acquired bloodstream infections, reaching a mortality rate of up to 35--40% for systemic or disseminated infections. Systemic mycoses can occur in patients with severely impaired immune systems, people with organ or bone marrow transplants, cancer patients undergoing chemotherapy or in intensive care unit patients, as well as both neonates and the elderly.\[[@ref1]\] Moreover, the pattern of candidal species causing infection impacts in the management of this disease. For example, *Candida glabrata* tends to have higher minimum inhibitory concentrations (MIC) values to the currently used antifungals, particularly the azoles.\[[@ref2]\]

Secreted aspartic proteases (SAP) have been described as a major virulence factor in *Candida* spp. infections. SAP could contribute to host tissue adhesion and invasion by degrading or distorting host cell surface structures and intercellular substances, or by destroying cells and molecules of the host immune system to avoid or resist antimicrobial attack.\[[@ref3]\] Several researches have been proposing that SAP could be an interesting target for new anti-candidal candidates from synthetic\[[@ref4][@ref5][@ref6]\] or natural\[[@ref7][@ref8]\] origins.

*Croton cajucara* Benth. (*Euphorbiaceae*) has been a very important traditional medicinal plant in Brazil.\[[@ref9][@ref10]\] Two morphotypes of *C. cajucara* are known, white "sacaca" and red "sacaca," mainly identified by young leaf color and steams.\[[@ref3]\] In general, essential oils (EO) from the white morphotype are rich in linalool, while those from red morphotype are rich in 7-hydroxycalamenene, although some exceptions have been registered.\[[@ref11][@ref12]\] The linalool-rich EO from the leaves of *C. cajucara* has been shown to be very toxic for *Leishmania amazonensis* and *Candida albicans*.\[[@ref13][@ref14]\] Actually, our group demonstrated that 7-hydroxycalamenene-rich EO from *C. cajucara* was effective against *L. chagasi*,\[[@ref15]\] *Mycobacterium* spp., *Staphylococcus aureus* MRSA, *Mucor polymorphosporus*, and *Rhizopus oryzae*.\[[@ref16]\]

7-Hydroxycalamenene is a hydroxylated sesquiterpene whose molecular weight is 218. It has been identified in *Eremophila drummondii* (*Scrophulariaceae*), *Ulmus glabra* (*Ulmaceae*), *Ganoderma applanatum* (*Ganodermataceae*), cotton leaves inoculated with *Xanthomonas campestris* pv. *malvacearum* (Malvaceae; Xanthomonadaceae), *Syzygium cumini* (Myrtaceae), *Bazzania trilobata* (*Lepidoziaceae*), and *Tilia europaea* (*Tiliaceae*). It shows good activity against *Botrytis cinerea*, *Cladosporium cucumerinum*, *Phytophthora infestans*, *Pyricularia oryzae*, and *Septoria tritici*.\[[@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23]\] Our group also demonstrated the promising activity of 7-hydroxycalamenene against some zygomycetes.\[[@ref24]\] Thus, the objective of this work was to evaluate the anti-candidal activity of 7-hydroxycalamenene isolated from *C. cajucara* EO.

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals {#sec2-1}
---------

All solvents used were spectroscopic grade from Tedia (Fairfield, OH, USA). Reagents were from Sigma-Aldrich (St Louis, MO, USA). Column chromatographic products were obtained from Merck (Darmstadt, Germany).

Plant material {#sec2-2}
--------------

The individual of red morphotype of *C. cajucara* was kept in the germplasm bank. The leaves were collected between 8 h and 9 h. A voucher specimen was deposited at EMBRAPA Amazon Occidental Herbarium (registry IAN 165013).

Essential oil extraction, analysis, and 7-hydroxycalamenene purification {#sec2-3}
------------------------------------------------------------------------

Extraction was performed as previously described.\[[@ref4]\] The EO was analyzed in an Agilent (Palo Alto, CA, USA) 6890N gas chromatograph fitted with a 5% phenyl --95% methyl silicone (HP-5, 30 m × 0.32 mm × 0.25 mm) fused silica capillary column. The analytical procedures were conducted in accordance to the protocol described by Vandendool and Kratz.\[[@ref25]\] Identification of the EO components was based on computer search using Wiley sixth Edition library of mass spectral data and by comparison of their calculated linear retention index with literature data.\[[@ref26]\] 7-Hydroxycalamenene was also identified by injection of the authentic standard.

The standard was prepared after isolation of the 7-hydroxycalamenene as described by Pereira *et al*.\[[@ref12]\] The purity of the material was over 98%.

Microorganisms {#sec2-4}
--------------

*C. albicans* (ATCC 10231), *C. albicans* serotype A (ATCC 36801), *C. albicans* serotype B (ATCC 36802), *Candida dubliniensis* (clinical isolated), *Candida parapsilosis* (ATCC 22019), *Candida famata* (clinical isolated), *Candida guilliermondii* (ATCC 6260), *Candida tropicalis* (clinical isolated), *Candida krusei* (clinical isolated), and *Candida glabrata* (ATCC 9003) were used for the anti-candidal tests. The yeasts were stored in specific culture media slanted tubes at 4°C. Prior to use, the microorganisms were grown in Sabouraud agar for 24 h at 37°C.

Inhibitory concentration assays {#sec2-5}
-------------------------------

The *in vitro* susceptibility was determined by the MIC determination method. The MICs of 7-hydroxycalamenene were determined by two-fold serial dilution as described by Clinical and Laboratory Standards Institute M-27.\[[@ref27]\] The microbicidal/microbiostatic concentrations were determined according to Khan *et al*.\[[@ref28]\] sub-culturing the test dilutions onto a specific fresh solid media and incubated further for 24 h. The experiments were made in triplicate. All experiments were repeated at least 3 times.

Influence of 7-hydroxycalamenene on *Candida* albicans biofilm formation {#sec2-6}
------------------------------------------------------------------------

*C. albicans* (ATCC10231) was grown as a biofilm in a 96-well microtiter plate as reported previously\[[@ref29]\] with some modifications. Briefly, *C. albicans* was grown in yeast-nitrogen base broth (YNB) supplemented with 50 mM glucose pH 7.0 at 37°C overnight. After incubation, the cells were resuspended at a density of 1 × 10^7^ cells/ml in YNB. Microtiter plate previously coated with 100 μl of fetal bovine serum for 30 min and washed once with phosphate buffer saline (PBS) 0.01M pH 7.2 was incubated with 100 μl of cell suspension for 90 min at 37°C. Nonadherent cells were removed by washing twice with PBS, and 100 μl of different concentrations of 7-hydroxycalamenene (two-fold serial dilution) diluted in YNB medium supplemented with 50 mM glucose were added to the wells. The plate was incubated for up to 24 h at 37°C. The exopolysaccharide matrix was evaluated as previously described.\[[@ref30][@ref31]\]

Secreted aspartic protease inhibition {#sec2-7}
-------------------------------------

*C. albicans* serotype A was grown in YEPD broth for 24 h at 25°C to optimize the SAP production.\[[@ref22]\] Cells were removed by centrifugation, and the supernatant was concentrated 25 times in an ultrafiltration cell (Amicon Corp.). The quantitative proteolytic activity was made according to Palmeira *et al*.\[[@ref32]\] with some modifications. Briefly, 20 μl of concentrated supernatant, 20 μl of bovine serum albumin (BSA) (0.1 mg/ml) and 60 μl of buffer solutions (pH 1.0--11.0) was added to a 96-well microtiter plate and incubated for 1 h at 37°C. After incubation, it was added 100 μl of Coomassie solution (0.025% Coomassie brilliant blue G-250, 11.75% ethanol, and 21.25% phosphoric acid). A control, where the substrate was added just after the reactions were stopped, was used as blank. After 10 min to allow dye binding, the plate was read on a Molecular Devices Thermomax microplate reader at an absorbance of 630 nm. One unit of enzyme activity was defined as the amount of enzyme that caused an increase of 0.001 in absorbance unit, under standard assay conditions. Alternatively, the concentrated supernatant was preincubated for 20 min at 37°C in the presence or absence of pepstatin A (10 mM) and 7-hydroxycalamenene (39.06 μg/ml). In this last case, the results were expressed as relative percentage of activity. Besides, the reaction mixtures were applied on sodium dodecyl sulfate polyacrylamide gel electrophoresis to demonstrate the fragments correspondent to the BSA hydrolysis; thus, the gels were stained with Coomassie blue R-250 solution.

RESULTS AND DISCUSSION {#sec1-3}
======================

The average EO yield obtained was 0.65% (dry weight). The compounds present in the EO from *C. cajucara* used are shown in [Table 1](#T1){ref-type="table"}. The percentage of 7-hydroxycalamenene on the EO was about 35.4%.

###### 

Main components from *C. cajucara* essential oil

![](PM-12-36-g002)

In previous work, our group evaluated the antioxidant and antimicrobial activities of 7-hydroxycalamenene-rich EO from *C. cajucara*. In that study, we demonstrated that 7-hydroxycalamenene was the main bioactive component of the EO.\[[@ref16]\] Here, we report for the 1^st^ time the anti-candidal activity of purified 7-hydroxycalamenene. The results of MIC assay using this substance can be observed in [Table 2](#T2){ref-type="table"}. Best results were observed against *C. albicans*, *C. albicans* serotype A, *C. dubliniensis* (MIC values at 39.06 μg/ml), but also against *C. albicans* serotype B (MIC value at 78.125 μg/ml). It is usually considered that strong activity is for MIC values between 50 and 500 μg/ml, moderate activity values between 600 μg/ml and 1500 μg/ml and above 1500 μg/ml as a weak activity.\[[@ref33]\] According to this classification it could be stated that 7-hydroxycalamenene presents high activity against *C. albicans*, *C. albicans* serotype A and *C. dubliniensis*, moderate activity against *C. albicans* serotype B, *C. parapsilosis* and *C. tropicalis*, and weak activity to *C. famata*, *C. guilliermondii*, *C. krusei* and *C. glabrata*, which shows that it is a promising antifungal substance mainly against *C. albicans*. Previously, we showed that the best MIC of 7-hydroxycalamenene-rich EO from *C. cajucara* for *C. albicans* was about 0.038 μg/ml. The strong activity presented by EO may be explained by its chemical composition. In fact, the EO has other components that may act synergistically in inhibiting the microorganisms.\[[@ref15]\]

###### 

MICs values (in μg/ml) of 7-OH

![](PM-12-36-g003)

Biofilm formation represents the most common mode of growth and environment resistance of some microorganisms. In fact, the ability of *Candida* spp. to form biofilms allows them to resist drugs and also to resist host immunological response during the course of infection. Raut *et al*.\[[@ref34]\] reported that eight more active phenylpropanoids of plant origin were able to significantly inhibit biofilm formation by *C. albicans* at concentrations ranging from 125 μg/ml to 512 μg/ml. Here, we evaluated the effects of 7-hydroxycalamenene on *C. albicans* biofilm formation. Our results revealed that 7-hydroxycalamenene did not affect biofilm formation at MIC value (39.06 μg/ml), but only at the concentration of 2500 μg/ml (27% of inhibition) \[Figures [1](#F2){ref-type="fig"} and [2](#F3){ref-type="fig"}\]. These results corroborate the literature data which describes that the microorganisms within biofilms display increased resistance to antimicrobials in comparison to their planktonic counterparts. This phenomenon is generally associated with poor antimicrobial penetration (due to the presence of an extracellular matrix), activation of adaptive stress responses (including the production of persisted cells and induction of quorum sensing mechanisms), and physiological heterogeneity within the biofilm population.\[[@ref35][@ref36]\] It is worth mentioning that IC~50~ and MIC values for biofilm inhibition have been described as 5--8 and 30--2000 times higher than for planktonic cells, respectively.\[[@ref37]\]

![Effect of 7-hydroxycalamenene against *Candida albicans* biofilm. The plates were incubated at 37°C for 24 h. (a) Biofilm control, (b) Biofilm treated with 2500 µg/ml of 7-hydroxycalamenene. The images were taken at ×40 using an inverted microscope](PM-12-36-g004){#F2}

![Percentage of biofilm of *Candida albicans* (ATCC 10231) at different concentrations of 7-hydroxycalamenene](PM-12-36-g005){#F3}

In order to evaluate the inhibitory effect of 7-hydroxycalamenene on SAP, we first establish the optimal pH condition for the enzymatic assay. The supernatant of YEPD culture *C. albicans* serotype A was collected and concentrated 25 times. Then, peptidase activity was detected under different pHs conditions. The highest hydrolysis level of BSA was detected at pH 7.0 \[[Figure 3a](#F4){ref-type="fig"}\]. Through the inhibition of pepstatin A \[Figures [3b](#F4){ref-type="fig"} and [3c](#F4){ref-type="fig"}\] our results suggest that the supernatant obtained was rich in SAP. These results are in accordance to those reported by White and Agabian.\[[@ref38]\] Therefore, the concentrated supernatant was incubated in the presence of 39.06 μg/ml (MIC) of 7-hydroxycalamenene at pH 7.0. After the incubation period, we observed a reduction of 58%in the SAP activity. There are few works in literature describing the inhibitory activity of plant extracts or their isolated bioactive components on SAP from *Candida* spp., making it a promising study field. Li *et al*.\[[@ref39]\] described SAP inhibitory activity of phenolic compounds isolated from *Miconia myriantha*. Mattucinol-7-O- (4' ', 6' '-O-\[S\]-hexahydroxydiphenoyl)-beta-D-glucopyranoside and galic acid displayed the best activities at IC~50~ values of 8.4 and 10.5 μM, respectively. SAP from *C. albicans* were also inhibit by two new xanthones, 1,3,5,7-tetrahydroxy-8-isoprenylxanthone and 1,3,5-trihydroxy-8-isoprenylxanthone, but also by 3-geranyl-2,46-trihydroxybenzophenone and betulinic acid obtained from *Tovomita krukovii*. The IC~50~ of these compounds were 15, 25, 40 and 6.5 μg/ml, respectively.\[[@ref7]\] The same research group described SAP inhibitory activity of apigenin-4'- O-(2'',6''- di-O-p-coumaroyl) -β-d-glucopyranoside and 3β, 14α, 15α, 21β-tetrahydroxyserratane-24-oic acid, both isolated from an ethanol extract of *Lycopodium cernuum*, at IC~50~ values of 20 and 8.5 μg/mL, respectively.\[[@ref8]\] It is interesting to note that among the compounds described above only 3-geranyl-2,46-trihydroxybenzophenone and 7-hydroxycalamene were also cytotoxic for the microorganism.

![(a) Effect of pH on extracellular proteolytic activity of *Candida albicans* serotype A. (b) Effect of Pepstatin A and 7-hydroxycalamenene on the secreted peptidase activity from *Candida albicans* serotype A. (c) Sodium dodecyl sulfate polyacrylamide gel electrophoresis: The system is at pH 5.0 where A is the bovine serum albumin control and B is the reaction with 7-hydroxycalamenene](PM-12-36-g006){#F4}

CONCLUSION {#sec1-4}
==========

This study provides biological evidence that 7-hydroxycalamenene, the major compound in *C. cajucara* (red morphotype) EO, is active against *Candida* spp. Our results demonstrate that despite its poor inhibitory activity on *Candida* biofilm formation, 7-hydroxycalamenene displayed strong activity against the planktonic cells. In addition, this substance was also able to inhibit SAP activity, an important *Candida* virulence factor. These results further support the potential use of 7-hydroxycalamenene in the combat against *Candida* spp.
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